• Email
  • Print
  • Share
  • Text
Highlight Glossary Terms
  • Pasi Jänne on new lung and colorectal cancer gene discovery
  • 1:35
  • The new frontier of cancer treatment, personalized medicine, involves identifying specific genetic abnormalities in cancerous cells and targeting them with drugs that are most likely to cause an effective response. Pasi Jänne, MD, PhD, discusses the discovery that some types of non-small cell lung cancer and colorectal cancer share similar genetic abnormalities with cancers that are known to respond to targeted therapies, and explains how this new knowledge can help identify patients with specific genetic mutations that might respond to existing drugs.

Tags: ColonCancer, Genomics, KinaseInhibitor, LungCancer, TargetedTherapy